High prevalence of a screening-detected, HFE-unrelated, mild idiopathic iron overload in Northern Italy.

BACKGROUND AND OBJECTIVES In Italy, typical HFE mutations account for only 64% of the cases with overt hereditary hemochromatosis (HH), and a common HFE-unrelated disease was hypothesized. DESIGN AND METHODS One thousand and fifty potential blood donors were screened by iron tests, C282Y and H63D HFE mutation analysis in a region in North Italy. Subjects with repeated fasting transferrin saturation of 45% or more and no secondary iron overload were defined as probands with idiopathic iron overload. To assess the inheritance of iron overload, relatives of probands were screened. RESULTS The overall frequency of probands with idiopathic iron overload was 3.43% (95% confidence interval, 2.32 to 4.52). Of these, 8.4% had genotypes associated with HH (compound heterozygous for H63D/C282Y or homozygous for H63D HFE mutations), and 91.6% had atypical genotypes: 47.2% were heterozygous for C282Y or H63D HFE mutations, and 44.4% had wild type/wild type genotype. A family history of iron overload was proven in 33.3% of probands with atypical genotypes (1.04% of the overall population). Pedigree analysis excluded linkage of heterozygous HFE mutations with iron overload (cumulative lod score 2.41) and documented a recessive non-HLA-linked locus accounting for iron overload in wild type/wild type genotypes. None of the probands had clinical signs of iron accumulation; in males, serum ferritin positively correlated with age (r=0.63, p<0.01), and the regression model predicted a serum ferritin of 700 ng/mL at the age of 58. INTERPRETATION AND CONCLUSIONS In Northern Italy an HFE-unrelated, mild idiopathic iron overload is highly prevalent. A recessive locus accounts for iron overload in at least 1.04% of the overall population.

[1]  A. Donovan,et al.  Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. , 2001, The Journal of clinical investigation.

[2]  L. Grummer-Strawn,et al.  Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States. , 2001, JAMA.

[3]  A. Pietrangelo,et al.  Frequency and biochemical expression of C282Y/H63D hemochromatosis (HFE) gene mutations in the healthy adult population in Italy. , 2001, Journal of hepatology.

[4]  B. Bacon,et al.  Hemochromatosis: diagnosis and management. , 2001, Gastroenterology.

[5]  G. Mancia,et al.  Two novel nonsense mutations of HFE gene in five unrelated italian patients with hemochromatosis. , 2000, Gastroenterology.

[6]  P. Fortina,et al.  A pilot C282Y hemochromatosis screening in Italian newborns by TaqMan technology. , 2000, Genetic testing.

[7]  Paolo Gasparini,et al.  The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22 , 2000, Nature Genetics.

[8]  J. Olynyk,et al.  A population-based study of the clinical expression of the hemochromatosis gene. , 1999, The New England journal of medicine.

[9]  M. Cogswell,et al.  Population-based screening for hemochromatosis using phenotypic and DNA testing among employees of health maintenance organizations in Springfield, Missouri. , 1999, The American journal of medicine.

[10]  M. Cazzola,et al.  Juvenile hemochromatosis locus maps to chromosome 1q. , 1999, American journal of human genetics.

[11]  C. Camaschella,et al.  Inherited HFE‐unrelated hemochromatosis in italian families , 1999, Hepatology.

[12]  J. Berg,et al.  High prevalence of the hemochromatosis-associated Cys282Tyr HFE gene mutation in a healthy Norwegian population in the city of Oslo, and its phenotypic expression. , 1999, Scandinavian journal of gastroenterology.

[13]  M. O'Leary,et al.  Prevalence of Hereditary Hemochromatosis in 16 031 Primary Care Patients , 1998, Annals of Internal Medicine.

[14]  D. Girelli,et al.  Heterogeneity of hemochromatosis in Italy. , 1998, Gastroenterology.

[15]  D. Hãussinger,et al.  Screening for Hemochromatosis and Iron Deficiency in Employees and Primary Care Patients in Western Germany , 1998, Annals of Internal Medicine.

[16]  Esin,et al.  HFE mutations in patients with hereditary haemochromatosis in Sweden , 1998, Journal of internal medicine.

[17]  G. McLachlan,et al.  GASTROENTEROLOGY 1998;114:543–549 Distribution of Transferrin Saturation in an Australian Population: Relevance to the Early Diagnosis , 2022 .

[18]  R. Oliva,et al.  Prevalence of the Cys282Tyr and His63Asp HFE gene mutations in Spanish patients with hereditary hemochromatosis and in controls. , 1998, Journal of hepatology.

[19]  I. Fellows,et al.  A high prevalence of HLA-H 845A mutations in hemochromatosis patients and the normal population in eastern England. , 1997, Blood cells, molecules & diseases.

[20]  D. Girelli,et al.  Mutation analysis of the HLA-H gene in Italian hemochromatosis patients. , 1997, American journal of human genetics.

[21]  Jennifer J. Pointon,et al.  Global prevalence of putative haemochromatosis mutations. , 1997, Journal of medical genetics.

[22]  J. Haddow,et al.  Population Screening for Haemochromatosis: A Unifying Analysis of Published Intervention Trials , 1996, Journal of medical screening.

[23]  M. C. Ellis,et al.  A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis , 1996, Nature Genetics.

[24]  A. R. Muir,et al.  Hepatic pathology in relatives of patients with haemochromatosis. , 1962, The Journal of pathology and bacteriology.